In a significant development for oncology care in Southeast Asia, Vietnam’s Ministry of Health has officially approved the circulation of Pembroria, a Russian-manufactured cancer drug containing the advanced immunotherapy agent pembrolizumab. This authorization, valid for three years, marks a pivotal step in broadening patient access to cutting-edge treatments and enhancing Vietnam’s medical landscape. A Modern Alternative … Continue reading Vietnam Approves Advanced Cancer Immunotherapy, Expanding Treatment Access